Biloba is a company.
Biloba has raised $3.0M across 2 funding rounds.
Key people at Biloba.
Biloba has raised $3.0M in total across 2 funding rounds.
Biloba has raised $3.0M in total across 2 funding rounds.
Biloba's investors include Accel, AirAngels, AngelList Syndicator, Benchmark, Blisce, Felix Capital, Christian Miele, Motier Ventures, Optum Ventures, Pareto Holdings, Partech Ventures, Picus Capital.
Key people at Biloba.
Biloba is a French digital health startup that provides on-demand medical chat consultations for parents seeking advice about their children. It builds a mobile app allowing users to text doctors, nurses, or general practitioners between 8 AM and 8 PM, addressing common parental concerns without needing a full pediatric visit.[4] The service solves the problem of quick, accessible health queries for first-time or busy parents, who often turn to unreliable forums, by offering professional responses for €10/month (waived during initial launch and lockdown).[4] Backed by Calm/Storm Ventures since 2020, Biloba operates in the digital health space with early traction of 4,000 users and 200 daily conversations within three weeks of launch.[1][4]
Biloba emerged in France as a solution to simplify child health management for parents. Prior to its chat service, the company released a vaccine reminder app, where users input their child's vaccine data to receive timely alerts for upcoming doses.[4] The core idea pivoted to broader telemedicine during the 2020 COVID-19 lockdown, launching a chat-based app to provide instant doctor access amid heightened parental anxieties.[4] This timing capitalized on restricted in-person visits, attracting rapid adoption without relying on video consultations, unlike competitors like Doctolib.[4] Specific founders are not detailed in available sources, but the startup quickly gained investor support from Calm/Storm Ventures, an exclusive founder network, marking a pivotal early milestone.[1]
Biloba stands out in pediatric telemedicine through these key features:
Biloba rides the telemedicine boom accelerated by COVID-19, particularly in digital health for family care, where parents seek frictionless advice amid forum misinformation.[4] Timing was ideal: France temporarily lifted reimbursement restrictions during lockdown, boosting adoption of non-covered services like Biloba's.[4] Favorable market forces include rising demand for scalable, async healthcare—text chats handle influxes better than video—and a gap in pediatric-specific tools beyond general platforms like Doctolib.[4] As a Calm/Storm portfolio company since 2020, it contributes to the startup ecosystem by validating niche telehealth models, potentially influencing investor focus on consumer-facing health tech in Europe.[1]
Biloba's text-first approach positions it for growth in a post-pandemic world favoring convenient, subscription-based health tools. Next steps likely include expanding beyond France, enhancing features like vaccine integration, and navigating reimbursement hurdles for sustainability.[4] Trends like AI-assisted triage and global parental health apps will shape its path, amplifying influence if it scales user base and partnerships. Ultimately, Biloba exemplifies how targeted digital health lowers everyday barriers, evolving from lockdown novelty to essential parent ally.[1][4]
Biloba has raised $3.0M across 2 funding rounds. Most recently, it raised $2.0M Seed in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2021 | $2.0M Seed | Accel, AirAngels, AngelList Syndicator, Benchmark, Blisce, Felix Capital, Christian Miele, Motier Ventures, Optum Ventures, Pareto Holdings, Partech Ventures, Picus Capital, Possible Ventures, Rainfall Ventures, Roosh Ventures, Seven Seven Six, Tusk Venture Partners, Vayner RSE, Andy Chung, Emmanuel Seuge, Mato Peric, Ross Devor, Scott Belsky | |
| Jul 1, 2020 | $1.0M Seed | Motier Ventures, Optum Ventures, Picus Capital, Rainfall Ventures, Roosh Ventures, Tusk Venture Partners, Ross Devor, Scott Belsky |
